Last year’s issue of Genome Technology took you inside the new Arizona cancer genomics initiative called the International Genomics Consortium. Since then, the IGC has continued to gain momentum. In March it named Michael Berens CEO, and Robert Penny as chief medical officer. And by June, the consortium heralded the groundbreaking of its home-to-be in downtown Phoenix. The $46 million facility, also occupied by the Translational Genomics Research Institute, is expected to be open in November of next year.